Product Details
Januvia
Sitagliptin Phosphate Monohydrate100 mg
Tablet
DIN/PIN/NPN
02303922
Manufacturer
Merck Frosst Canada Ltd.
Formulary Listing Date
2010-06-14
Unit Price
3.2787
Amount MOH Pays
0.8197
Coverage Status
General Benefit Chronic-Use Medication Insulin or Oral Hypoglycemic Product
ODB Formulary Therapeutic Classification
Therapeutic Note
Sitagliptin Phosphate Monohydrate 100 mg Tablet: Treatment of Type 2 diabetes in patients on maximal doses of metformin (2000mg/day) who have: . Inadequate glycemic control (defined as HbA1c>0.07) and intolerance or contraindication to a sulfonylurea; or . Inadequate glycemic control (HbA1c>0.07) and on maximal doses of a sulfonylurea and for whom insulin is not an option.
ATC Code
A10BH01
Interchangeable Products
| DIN/ PIN/ NPN | Brand name | Unit Price | Amount MOH pays |
|---|---|---|---|
| 02303922 | Januvia | 3.2787 | 0.8197 |
| 02508672 | Apo-Sitagliptin Malate | 0.8197 | 0.8197 |
| 02529882 | Auro-Sitagliptin | 0.8197 | 0.8197 |
| 02534150 | Jamp Sitagliptin | 0.8197 | 0.8197 |
| 02504065 | Sandoz Sitagliptin | 0.8197 | 0.8197 |
| 02529068 | Sitagliptin | 0.8197 | 0.8197 |
| 02531666 | Taro-Sitagliptin Fumarate | 0.8197 | 0.8197 |
| 02512491 | Ach-Sitagliptin | 0.8197 | 0.8197 |
| 02522721 | Teva-Sitagliptin Malate | 0.8197 | 0.8197 |